Severe dermographism after topical therapy with diphenylcyclopropenone for alopecia universalis

Contact Dermatitis

Volumn 42, Issue 4, 2000, Pages 212-215

  Skrebova, Natalja ^a,b   Nameda, Yumiko ^a   Takiwaki, Hirotsugu ^a   Arase, Seiji ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b TARTU UNIVERSITY HOSPITAL   (Estonia)

Author keywords

Allergic contact dermatitis; Alopecia areata; Contact immunotherapy; Diphenylcyclopropenone; Immune responses to contact allergens; Medicaments; Urticaria

Indexed keywords

DIPHENCYPRONE;

ADULT; ALOPECIA; ARTICLE; CASE REPORT; CONTACT DERMATITIS; DERMOGRAPHISM; ERYTHEMA; HUMAN; IMMUNOTHERAPY; LASER DOPPLER FLOWMETRY; MALE; PRESSURE MEASUREMENT; SCALP; URTICARIA;

ADMINISTRATION, TOPICAL; ADULT; ALOPECIA; CYCLOPROPANES; DERMATITIS, ALLERGIC CONTACT; HUMANS; LASER-DOPPLER FLOWMETRY; MALE; PROGNOSIS; SCALP DERMATOSES; SEVERITY OF ILLNESS INDEX; URTICARIA;

EID: 0034024970     PISSN: 01051873     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0536.2000.042004212.x     Document Type: Article

References (12)

1. Rokhsar K C, Shupack L J, Vafai J J et al. Efficacy of topical sensitizers in the treatment of alopecia areata. J Am Acad Dermatol 1998: 39: 751-761.
2. Alam M, Gross A E, Savin R C. Severe urticarial reaction to diphenylcyclopropenone therapy for alopecia areata. J Am Acad Dermatol 1999: 40: 110-111.
3. Dawber R P R, De Berker D, Wojnarowska F. Disorders of hair. In: Textbook of dermatology, Champion R H, Burton J L, Burns D A, Breathnack S M (eds): 6th edition, vol. 4. Oxford: Blackwell Scientific Publications, 1998: 2926-2927.
4. Bircher A, De Boer E M, Agner T et al. Guidelines for measurement of cutaneous blood flow by laser Doppler flowmetry: A report from the Standardization Group of the European Society of Contact Dermatitis. Contact Dermatitis 1994: 30: 65-72.
5. Tosti A, Guerra L, Bardazzi F. Contact urticaria during topical immunotherapy. Contact Dermatitis 1989: 21: 196-197.
6. Berth-Jones J, McBurney A, Hutchinson P. Diphencyprone is not detectable in serum or urine following topical application. Acta Dermato-venereologica 1994: 74: 312-313.
7. Orecchia G. The "castling" phenomenon: a possible explanation. Eur J Dermatol 1994: 4: 161.
8. Happle R. Topical immunotherapy in alopecia areata. J Invest Dermatol 1991: 96 (suppl): 71S.
9. Gordon P M, Aldridge R D, McVittie E, Hunter J A A. Topical diphencyprone for alopecia areata: evaluation of cases after 30 months' follow-up. Br J Dermatol 1996: 134: 869-871.
10. Pericin M, Trueb R M. Topical immunotherapy of severe alopecia areata with diphenylcyclopropenone: evaluation of 68 cases. Dermatology 1998: 196: 418-421.
11. Weise K, Kretzschmar L, John S M, Hamm H. Topical immunotherapy in alopecia areata: anamnestic and clinical criteria of prognostic significance. Dermatology 1996: 192: 129-133.
12. Consensus Meeting on the definition of physical urticarias and urticarial vasculitis. Clin Exp Dermatol 1996: 21: 424-426.